Long-term health outcomes associated with detectable troponin I concentrations.
about
Association between angiotensin-converting enzyme inhibitors and troponin in acute coronary syndrome.Increasing serum troponin I and early prognosis in patients with chest pain or angina equivalent symptoms in the emergency department"Upstream markers" provide for early identification of patients at high risk for myocardial necrosis and adverse outcomes.The use of a cytokine panel to define the long-term risk stratification of heart failure/death in patients presenting with chest pain to the emergency department.Identification of myocardial injury in the emergency setting.Short- and long-term risk stratification using a next-generation, high-sensitivity research cardiac troponin I (hs-cTnI) assay in an emergency department chest pain population.Vascular versus myocardial dysfunction in acute coronary syndrome: are the adhesion molecules as powerful as NT-proBNP for long-term risk stratification?Is a pattern of increasing biomarker concentrations important for long-term risk stratification in acute coronary syndrome patients presenting early after the onset of symptoms?Biomarkers in Acute Coronary Syndrome.PAPP-A as a marker of increased long-term risk in patients with chest pain.Circulating miRNAs: novel biomarkers of acute coronary syndrome?Sex-specific versus overall cut points for a high sensitivity troponin I assay in predicting 1-year outcomes in emergency patients presenting with chest pain.Age-sex distribution of patients with high-sensitivity troponin T levels below the 99th percentile.Recommendations for the use of cardiac troponin measurement in acute cardiac care
P2860
Q34914616-57F0EA2B-D0CF-4EDB-A361-3CEDC07A0BA9Q36348833-C21ED16E-3035-4A9C-A82D-637B847BB6ECQ36601665-C1174F7F-7AB9-4DC4-934F-F1619B5BE146Q36601675-D46AA8A0-1B87-47EE-B74A-FBDF94F7A089Q36601679-4BDEFD63-9848-4078-BC8E-D6139D3A4703Q36601689-B68600C6-E54D-4F49-9013-C42556361523Q36601693-4899B254-0ED8-4EB4-900C-2CFD93B6A3D8Q36601701-0AB4A118-BB65-44F7-B931-A8AA4E074C98Q37207294-F8CCAB0C-4E63-450B-95E1-299EACF9B700Q37696962-6AF9474D-89CD-4F89-821B-4FA497B87E8CQ38095110-90752BAA-60CF-41AA-B3E4-18C5DC030D08Q40146915-C90569A6-BC43-47AA-AED0-FA0D26A1FAB4Q45374847-DC492F5F-1695-4659-A819-B360CB8DF7F1Q58314269-9F07965C-763F-4081-B031-3C390DE3F615
P2860
Long-term health outcomes associated with detectable troponin I concentrations.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Long-term health outcomes associated with detectable troponin I concentrations.
@en
type
label
Long-term health outcomes associated with detectable troponin I concentrations.
@en
prefLabel
Long-term health outcomes associated with detectable troponin I concentrations.
@en
P2093
P1433
P1476
Long-term health outcomes associated with detectable troponin I concentrations.
@en
P2093
Alice M Newman
Allan S Jaffe
Andrew R MacRae
Glenn E Palomaki
Peter A Kavsak
Viliam Lustig
P304
P356
10.1373/CLINCHEM.2006.076885
P407
P577
2007-01-04T00:00:00Z